With the continuing growth in both medical device and bio-technology solutions, successful conduct of any clinical trial is crucially important for future commercialization. However, it has been reported that nearly 70% of randomized clinical trials have either required an extension to the patient recruitment period or have failed to meet their recruitment targets.